Michelle Straub
17Patents
8h-index
11Co-inventors
61Inventor score
Filing activity: Jul 9, 2015 → Sep 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9573995B2 | Compositions and methods for growth factor modulation | Physics | 39 | Active |
| US9580500B2 | Compositions and methods for growth factor modulation | Physics | 34 | Active |
| US9399676B2 | Compositions and methods for growth factor modulation | Physics | 32 | Active |
| US10597443B2 | Compositions and methods for growth factor modulation | Physics | 13 | Active |
| US9758577B2 | Compositions and methods for growth factor modulation | Physics | 10 | Active |
| US9758576B2 | Compositions and methods for growth factor modulation | Physics | 10 | Active |
| US10287345B2 | Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies | Chemistry; Metallurgy | 10 | Active |
| US10307480B2 | Anti-pro/latent-myostatin antibodies and uses thereof | Physics | 9 | Active |
| US10751413B2 | Anti-pro/latent-Myostatin antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11135291B2 | Methods for making and using anti-myostatin antibodies | Physics | 5 | Active |
| US10882904B2 | Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies | Chemistry; Metallurgy | 4 | Active |
| US10946036B2 | Use of myostatin inhibitors and combination therapies | Chemistry; Metallurgy | 4 | Active |
| US11439704B2 | Methods for using anti-myostatin antibodies | Chemistry; Metallurgy | 3 | Active |
| US10981981B2 | Compositions and methods for growth factor modulation | Physics | 2 | Active |
| US12006359B2 | Methods for altering body composition by administering anti-pro/latent myostatin antibodies | Chemistry; Metallurgy | 1 | Active |
| US11925683B2 | Compositions for making and using anti-Myostatin antibodies | Physics | 1 | Active |
| US11827698B2 | Compositions and methods for growth factor modulation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.